| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | INTRA-CELLULAR THERAPIES INC | 609,166 | 9,192,000 | 0.09% | ||
| 52 | ALKERMES PLC | 150,251 | 8,351,000 | 0.08% | ||
| 53 | ABEONA THERAPEUTICS INC | 1,684,364 | 8,169,000 | 0.08% | ||
| 54 | ACHILLION PHARMACEUTICALS IN | 1,856,637 | 7,668,000 | 0.08% | ||
| 55 | LIGAND PHARMACEUTICALS INC | 73,386 | 7,457,000 | 0.07% | ||
| 56 | MACROGENICS INC | 363,676 | 7,434,000 | 0.07% | ||
| 57 | CONTRAFECT CORP COM | 4,045,876 | 7,080,000 | 0.07% | ||
| 58 | IMMUNOGEN INC | 3,015,353 | 6,151,000 | 0.06% | ||
| 59 | DIMENSION THERAPEUTICS INC | 1,251,881 | 5,446,000 | 0.05% | ||
| 60 | AGIOS PHARMACEUTICALS INC | 128,666 | 5,369,000 | 0.05% | ||
| 61 | CATALYST PHARMACEUTICALS INC | 5,102,153 | 5,357,000 | 0.05% | ||
| 62 | INSMED INC | 400,000 | 5,292,000 | 0.05% | ||
| 63 | INOTEK PHARMACEUTICALS CORP | 5,000,000 | 5,167,000 | 0.05% | PRN | |
| 64 | ALCOBRA LTD | 2,336,359 | 4,906,000 | 0.05% | ||
| 65 | RIGEL PHARMACEUTICAL INC | 2,018,882 | 4,805,000 | 0.05% | ||
| 66 | BIOGEN INC | 16,500 | 4,679,000 | 0.05% | ||
| 67 | Aevi Genomic Medicine Inc | 880,539 | 4,561,000 | 0.04% | ||
| 68 | ALDER BIOPHARMACEUTICALS INC | 217,328 | 4,520,000 | 0.04% | ||
| 69 | LOXO ONCOLOGY INC COM | 137,735 | 4,423,000 | 0.04% | ||
| 70 | ARRAY BIOPHARMA INC 3 06/01/2020 | 3,000,000 | 4,195,000 | 0.04% | PRN | |
| 71 | STEMLINE THERAPEUTICS INC | 333,497 | 3,568,000 | 0.03% | ||
| 72 | ULTRAGENYX PHARMACEUTICAL INC COM | 50,000 | 3,516,000 | 0.03% | ||
| 73 | AKARI THERAPEUTICS PLC | 496,901 | 3,498,000 | 0.03% | ||
| 74 | MINERVA NEUROSCIENCES INC COM | 258,805 | 3,041,000 | 0.03% | ||
| 75 | ASSEMBLY BIOSCIENCES INC | 250,000 | 3,038,000 | 0.03% | ||
| 76 | IGNYTA INC COM | 571,000 | 3,026,000 | 0.03% | ||
| 77 | SELECTA BIOSCIENCES INC | 175,712 | 3,013,000 | 0.03% | ||
| 78 | Natera, Inc. | 249,269 | 2,919,000 | 0.03% | ||
| 79 | ADAMAS PHARMACEUTICALS INC | 172,630 | 2,917,000 | 0.03% | ||
| 80 | EPIZYME INC COM | 232,481 | 2,813,000 | 0.03% | ||
| 81 | IONIS PHARMACEUTICALS INC COM | 57,140 | 2,733,000 | 0.03% | ||
| 82 | RA PHARMACEUTICALS INC COM | 177,952 | 2,703,000 | 0.03% | ||
| 83 | Sunesis Pharmaceuticals, Inc. | 741,665 | 2,685,000 | 0.03% | ||
| 84 | TREVENA INC | 450,000 | 2,646,000 | 0.03% | ||
| 85 | ENANTA PHARMACEUTICALS INC | 75,357 | 2,524,000 | 0.02% | ||
| 86 | SYROS PHARMACEUTICALS INC | 204,465 | 2,486,000 | 0.02% | ||
| 87 | OSIRIS THERAPEUTICS INC NEW COM | 499,193 | 2,451,000 | 0.02% | ||
| 88 | TRILLIUM THERAPEUTICS INC | 413,697 | 2,337,000 | 0.02% | ||
| 89 | GLYCOMIMETICS INC | 381,235 | 2,326,000 | 0.02% | ||
| 90 | PROTALIX BIOTHERAPEUTICS INC | 3,423,000 | 2,293,000 | 0.02% | PRN | |
| 91 | CORBUS PHARMACEUTICALS HLDGS | 260,129 | 2,198,000 | 0.02% | ||
| 92 | ADR - Nabriva Therapeutics AG- Usd | 350,000 | 2,086,000 | 0.02% | ||
| 93 | KARYOPHARM THERAPEUTICS INC COM | 216,990 | 2,040,000 | 0.02% | ||
| 94 | AEGLEA BIOTHERAPEUTICS INC | 404,230 | 1,758,000 | 0.02% | ||
| 95 | Spring Bank Pharmaceuticals In | 219,298 | 1,752,000 | 0.02% | ||
| 96 | INVIVO THERAPEUTICS HLDGS CORPORATION COM NEW | 400,000 | 1,680,000 | 0.02% | ||
| 97 | CONCERT PHARMACEUTICALS INCORPORATED | 152,964 | 1,574,000 | 0.02% | ||
| 98 | JUNO THERAPEUTICS INC COM | 80,000 | 1,508,000 | 0.01% | ||
| 99 | SCYNEXIS INC | 467,600 | 1,492,000 | 0.01% | ||
| 100 | FULGENT GENETICS INC | 125,000 | 1,446,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-008836, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
